Contact Us  
Home  |  About Us   |  Investor Services   
Equity
   Equity Analysis
  News Analysis
  Corporate Action
  Other Market
  Company Profile
Derivatives
IPO
BSE Company News
Zydus Lifesciences Ltd.
BSE Code 532321
ISIN Demat INE010B01027
Book Value (Rs) 143.63
NSE Code ZYDUSLIFE
Dividend Yield % 0.63
Market Cap(Rs Mn) 953809.20
TTM PE(x) 37.74
TTM EPS(Rs) 25.11
Face Value (Rs) 1  
Industry : Pharmaceuticals & Drugs
  
26-Apr-2024 Zydus Lifesciences gets USFDA’s final approval fo...
24-Apr-2024 USFDA concludes inspection at Zydus Lifesciences’...
24-Apr-2024 Zydus Lifesciences informs about disclosure
23-Apr-2024 Zydus Lifesciences gets nod for new drug applicat...
23-Apr-2024 Zydus Lifesciences edges higher on getting nod fo...
22-Apr-2024 Zydus Lifesciences launches Mirabegron Extended-R...
22-Apr-2024 Zydus Lifesciences’ arm gets UK MHRA’s approval f...
22-Apr-2024 Zydus Lifesciences informs about press release
22-Apr-2024 Zydus Lifesciences surges on launching Mirabegron...
08-Apr-2024 Zydus Lifesciences informs about compliances-cert...
28-Mar-2024 USFDA completes inspection at Zydus Lifesciences’...
28-Mar-2024 Zydus Lifesciences informs about disclosure
26-Mar-2024 Zydus Lifesciences climbs on getting USFDA’s tent...
23-Mar-2024 Zydus Lifesciences gets USFDA’s tentative approva...
23-Mar-2024 Zydus Lifesciences informs about press release
Page 1 of 6
Prev || Next